Delivering COVID-19 vaccine trials at speed: the implementation of a phase IV UK multi-centre randomised controlled trial to determine safety and immunogenicity of COVID-19 vaccines co-administered with seasonal influenza vaccines (ComFluCOV)

被引：0
|
作者：
Sarah Baos
Rachel Todd
Russell Thirard
Rosie Harris
Jana Kirwan
Katherine Joyce
David Hutton
Adam Finn
Madeleine Clout
Heike Cappel-Porter
Chris A Rogers
Rajeka Lazarus
Lucy Culliford
机构：
[1] University of Bristol,Bristol Trials Centre
[2] University of Bristol,Bristol Vaccine Centre, Schools of Population Health Sciences and of Cellular and Molecular Medicine
[3] University Hospitals Bristol and Weston NHS Foundation Trust,undefined
来源：
Trials | / 25卷
关键词：
COVID-19 vaccine; Influenza vaccine; Randomised controlled trial (RCT); Efficient delivery; Urgent Public Health (UPH);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Randomised controlled trials of behavioural nudges delivered through text messages to increase influenza and COVID-19 vaccines among pregnant women (the EPIC study): study protocol
    Prabha H. Andraweera
    Bing Wang
    Margie Danchin
    Christopher Blyth
    Ivo Vlaev
    Jason Ong
    Jodie Dodd
    Jennifer Couper
    Thomas R. Sullivan
    Jonathan Karnon
    Nicola Spurrier
    Michael Cusack
    Dylan Mordaunt
    Dimi Simatos
    Gus Dekker
    Samantha Carlson
    Jane Tuckerman
    Nicholas Wood
    Lisa Whop
    Helen S. Marshall
    Trials, 24
  • [22] How inclusive were UK-based randomised controlled trials of COVID-19 vaccines? A systematic review investigating enrolment of Black adults and adult ethnic minorities
    Herieka, Hibba
    Babalis, Daphne
    Tzala, Evangelia
    Budhathoki, Shyam
    Johnson, Nicholas A.
    TRIALS, 2024, 25 (01)
  • [23] Efficacy and safety of oral ivermectin in the treatment of mild to moderate Covid-19 patients: a multi-centre double-blind randomized controlled clinical trial
    Wijewickrema, Ananda
    Banneheke, Hasini
    Pathmeswaran, Arunasalam
    Refai, Fathima Wardha
    Kauranaratne, Malika
    Malavige, Neelika
    Jeewandara, Chandima
    Ekanayake, Mahendra
    Samaraweera, Dilhar
    Thambavita, Dhanusha
    Galappatthy, Priyadarshani
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [24] Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
    Munro, Alasdair P. S.
    Janani, Leila
    Cornelius, Victoria
    Aley, Parvinder K.
    Babbage, Gavin
    Baxter, David
    Bula, Marcin
    Cathie, Katrina
    Chatterjee, Krishna
    Dodd, Kate
    Enever, Yvanne
    Gokani, Karishma
    Goodman, Anna L.
    Green, Christopher A.
    Harndahl, Linda
    Haughney, John
    Hicks, Alexander
    van der Klaauw, Agatha A.
    Kwok, Jonathan
    Lambe, Teresa
    Libri, Vincenzo
    Llewelyn, Martin J.
    McGregor, Alastair C.
    Minassian, Angela M.
    Moore, Patrick
    Mughal, Mehmood
    Mujadidi, Yama F.
    Murira, Jennifer
    Osanlou, Orod
    Osanlou, Rostam
    Owens, Daniel R.
    Pacurar, Mihaela
    Palfreeman, Adrian
    Pan, Daniel
    Rampling, Tommy
    Regan, Karen
    Saich, Stephen
    Salkeld, Jo
    Saralaya, Dinesh
    Sharma, Sunil
    Sheridan, Ray
    Sturdy, Ann
    Thomson, Emma C.
    Todd, Shirley
    Twelves, Chris
    Read, Robert C.
    Charlton, Sue
    Hallis, Bassam
    Ramsay, Mary
    Andrews, Nick
    LANCET, 2021, 398 (10318): : 2258 - 2276
  • [25] Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study
    Kulkarni, Prasad S.
    Kadam, Abhijit
    Godbole, Sheela
    Bhatt, Varsha
    Raut, Abhishek
    Kohli, Sunil
    Tripathi, Santanu
    Kulkarni, Praveen
    Ludam, Rakhi
    Prabhu, Madhav
    Bavdekar, Ashish
    Gogtay, Nithya J.
    Meshram, Sushant
    Kadhiravan, Tamilarasu
    Kar, Sonali
    Narayana, D. H. Ashwath
    Samuel, Clarence
    Kulkarni, Govind
    Gaidhane, Abhay
    Sathyapalan, Dipu
    Raut, Sidram
    Hadda, Vijay
    Bhalla, Hira Lal
    Bhamare, Chetanraj
    Dharmadhikari, Abhijeet
    Plested, Joyce S.
    Cloney-Clarke, Shane
    Zhu, Mingzhu
    Pryor, Melinda
    Hamilton, Stephanie
    Thakur, Madhuri
    Shete, Ashwini
    Gautam, Manish
    Gupta, Nivedita
    Panda, Samiran
    Shaligram, Umesh
    Poonawalla, Cyrus S.
    Bhargava, Barlam
    Gunale, Bhagwat
    Kapse, Dhananjay
    LANCET REGIONAL HEALTH - SOUTHEAST ASIA, 2023, 10
  • [26] Safety and immunogenicity after 2 doses of the BNT162b2 COVID-19 vaccine in an early-phase oncology trial centre population
    Malissen, Nausicaa
    Ninove, Laetitia
    de Lamballerie, Xavier
    Andre, Nicolas
    Gaudy-Marqueste, Caroline
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : 125 - 126
  • [27] Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial
    Xia, ShengLi
    Zhang, YunTao
    Wang, YanXia
    Wang, Hui
    Yang, YunKai
    Gao, George Fu
    Tan, WenJie
    Wu, GuiZhen
    Xu, Miao
    Lou, ZhiYong
    Huang, WeiJin
    Xu, WenBo
    Huang, BaoYing
    Wang, Wei
    Zhang, Wei
    Li, Na
    Xie, ZhiQiang
    Zhu, Xiujuan
    Ding, Ling
    You, WangYang
    Zhao, YuXiu
    Zhao, Jun
    Huang, LiLi
    Shi, XueZhong
    Yang, YongLi
    Xu, GuangXue
    Wang, WenLing
    Liu, PeiPei
    Ma, Meng
    Qiao, YuLing
    Zhao, SuHua
    Chai, JingJing
    Li, QinQin
    Fu, Hui
    Xu, Ying
    Zheng, XiaoTong
    Guo, WanShen
    Yang, XiaoMing
    LANCET INFECTIOUS DISEASES, 2022, 22 (02): : 196 - 208
  • [28] Safety of co-administration of mRNA COVID-19 and seasonal inactivated influenza vaccines in the vaccine adverse event reporting system (VAERS) during July 1, 2021-June 30, 2022
    Moro, Pedro L.
    Zhang, Bicheng
    Ennulat, Carol
    Harris, Margaret
    McVey, Rachel
    Woody, Gina
    Marquez, Paige
    McNeil, Michael M.
    Su, John R.
    VACCINE, 2023, 41 (11) : 1859 - 1863
  • [29] Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial
    Jan Maláska
    Jan Stašek
    František Duška
    Martin Balík
    Jan Máca
    Jan Hruda
    Tomáš Vymazal
    Olga Klementová
    Jan Zatloukal
    Tomáš Gabrhelík
    Pavel Novotný
    Regina Demlová
    Jana Kubátová
    Jana Vinklerová
    Adam Svobodník
    Milan Kratochvíl
    Jozef Klučka
    Roman Gál
    Mervyn Singer
    Trials, 22
  • [30] Immunogenicity, durability, and safety of an mRNA and three platform-based COVID-19 vaccines as a third dose following two doses of CoronaVac in China: A randomised, double-blinded, placebo-controlled phase 2 trial
    Zhang, Yuemiao
    Ma, Xupu
    Yan, Guanghong
    Wu, Ying
    Chen, Yanli
    Zhou, Zumi
    Wan, Na
    Su, Wei
    Liu, Feng-Wei
    Dai, Mu-Xian
    Yang, Mei
    Li, Chunmei
    Yu, Xuanjing
    Zhang, Liang
    Wang, Zhongfang
    Zhou, Tai-Cheng
    You, Dingyun
    Wei, Jia
    Zhang, Zijie
    Precise CoVaccine study grp, behalf of the Precise-CoVaccine study group
    ECLINICALMEDICINE, 2022, 54
12345